Indonesian Registry on Atrial Fibrillation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04222868

Acronym

OneAF

Enrollment

1000

Registered

2020-01-10

Start date

2019-01-01

Completion date

2021-12-30

Last updated

2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

atrial fibrillation, registry, anticoagulant

Brief summary

Our rationale of creation of this registry stems from the fact that the use of VKA in patients with AF is a double-edged sword, physicians face tremendous burden in assigning patients with VKA, due to risk of Bleeding complications despite its potential benefit. We intend to seek a safe and beneficial range of INR on Indonesian patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \>18 years old * Diagnosis of valvular or nonvalvular AF

Exclusion criteria

* Reversible AF * Patients who have been enrolled as a respondent on other clinical studies

Design outcomes

Primary

Measure	Time frame	Description
Number of Participants with Major Adverse Cardiovascular Events	24 months	Major Adverse Cardiovascular Events including stroke/transient ischemic attack, thromboembolism, acute coronary syndrome
Number of Participants with Bleeding Events	24 months	Intracranial bleeding, gastrointestinal bleeding
Mortality Rate	24 months	All-cause Mortality

Countries

Indonesia

Contacts

Primary ContactSunu B Raharjo, MD, PhD

sunu.b.raharjo@gmail.com6281385044810

Outcome results